BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25273809)

  • 1. Metformin, cancer and glucose metabolism.
    Salani B; Del Rio A; Marini C; Sambuceti G; Cordera R; Maggi D
    Endocr Relat Cancer; 2014; 21(6):R461-71. PubMed ID: 25273809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspective for an old antidiabetic drug: metformin as anticancer agent.
    Leone A; Di Gennaro E; Bruzzese F; Avallone A; Budillon A
    Cancer Treat Res; 2014; 159():355-76. PubMed ID: 24114491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and cancer therapy.
    Bost F; Sahra IB; Le Marchand-Brustel Y; Tanti JF
    Curr Opin Oncol; 2012 Jan; 24(1):103-8. PubMed ID: 22123231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin as an Anticancer Agent.
    Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
    Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New perspectives for metformin in cancer therapy].
    Loubière C; Dirat B; Tanti JF; Bost F
    Ann Endocrinol (Paris); 2013 May; 74(2):130-6. PubMed ID: 23587351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment.
    Sui X; Xu Y; Wang X; Han W; Pan H; Xiao M
    Mol Pharm; 2015 Nov; 12(11):3783-91. PubMed ID: 26430787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Metabolic Reprogramming and Mitochondrial Activity in Cancer Cells. Understanding The Anticancer Effect of Metformin and Its Clinical Implications.
    Cazzaniga M; Bonanni B
    Anticancer Res; 2015 Nov; 35(11):5789-96. PubMed ID: 26503999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing lipid metabolism in proliferating cells: new perspective for metformin usage in cancer therapy.
    Lettieri Barbato D; Vegliante R; Desideri E; Ciriolo MR
    Biochim Biophys Acta; 2014 Apr; 1845(2):317-24. PubMed ID: 24569230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin: from mechanisms of action to therapies.
    Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
    Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin as an antitumor agent in cancer prevention and treatment.
    Li D
    J Diabetes; 2011 Dec; 3(4):320-7. PubMed ID: 21631893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin: a new option in cancer treatment.
    Belda-Iniesta C; Pernía O; Simó R
    Clin Transl Oncol; 2011 Jun; 13(6):363-7. PubMed ID: 21680296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin: An anti-diabetic drug to fight cancer.
    Daugan M; Dufaÿ Wojcicki A; d'Hayer B; Boudy V
    Pharmacol Res; 2016 Nov; 113(Pt A):675-685. PubMed ID: 27720766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targets of metformin antitumor action.
    Sośnicki S; Kapral M; Węglarz L
    Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
    Lv Y; Tian N; Wang J; Yang M; Kong L
    J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin targets multiple signaling pathways in cancer.
    Lei Y; Yi Y; Liu Y; Liu X; Keller ET; Qian CN; Zhang J; Lu Y
    Chin J Cancer; 2017 Jan; 36(1):17. PubMed ID: 28126011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia.
    Rosilio C; Ben-Sahra I; Bost F; Peyron JF
    Cancer Lett; 2014 May; 346(2):188-96. PubMed ID: 24462823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin: an old drug with new potential.
    Hajjar J; Habra MA; Naing A
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1511-7. PubMed ID: 23978196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial metabolism and type-2 diabetes: a specific target of metformin.
    Leverve XM; Guigas B; Detaille D; Batandier C; Koceir EA; Chauvin C; Fontaine E; Wiernsperger NF
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S88-94. PubMed ID: 14502105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
    Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
    Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.